Genmab GMAB
$50.60 −$0.75 (-1.46%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $50.02 -1.15%
Open$51.57
Prev close$51.35
Day range$50.24 – $51.72
Volume2.90M
Market cap$31.20B
P/E (TTM)43.2
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$1.19B+16.1% YoY
Operating profit$441.00M-3.9% YoY
Net profit$342.00M-14.7% YoY
Diluted EPS$0.55-14.7% YoY
Free cash flow$509.00M-4.7% YoY
Operating cash flow$520.00M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin92.7%
Operating margin30.6%
Net margin17.0%
Return on equity12.1%
Return on assets7.3%
Return on invested capital11.1%
Current ratio2.45
Liabilities / assets51.0%
Cash & investments$1.86B
Total debt$5.17B
Net cash (debt)-$3.31B
Free cash flow / sales19.6%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $1.19B | $1.16B | $896.00M | $3.72B | $1.06B |
| Total Operating Revenue | $1.19B | $1.16B | $896.00M | $3.72B | $1.06B |
| Cost of Revenue | $88.00M | $84.00M | $65.00M | $238.00M | $81.00M |
| Gross Profit | $1.10B | $1.07B | $831.00M | $3.48B | $977.00M |
| Operating Expense | $658.00M | $664.00M | $606.00M | $2.23B | $734.00M |
| Selling and Admin Expenses | $196.00M | $205.00M | $166.00M | $626.00M | $208.00M |
| Research & Development | $451.00M | $459.00M | $440.00M | $1.61B | $535.00M |
| Depreciation & Amortization & Depletion | $11.00M | – | – | – | – |
| -Depreciation & Amortization | $11.00M | – | – | – | – |
| Operating Profit | $441.00M | $407.00M | $225.00M | $1.25B | $243.00M |
| Net Non-Operating Interest Income (Expense) | -$86.00M | -$74.00M | -$98.00M | $77.00M | $4.00M |
| Non-Operating Interest Income | $25.00M | $36.00M | $14.00M | $138.00M | $48.00M |
| Non-Operating Interest Expense | $111.00M | $110.00M | $112.00M | $61.00M | $44.00M |
| Other Income (Expense) | -$1.00M | -$38.00M | -$53.00M | -$123.00M | -$192.00M |
| Gain on Sale of Security | $9.00M | -$6.00M | -$8.00M | $62.00M | -$7.00M |
| Special Income (Charges) | -$10.00M | -$32.00M | -$45.00M | -$185.00M | -$185.00M |
| -Less:Restructuring and Mergern & Acquisition | $10.00M | $32.00M | $45.00M | $185.00M | $185.00M |
| Pretax Profit | $354.00M | $295.00M | $74.00M | $1.20B | $55.00M |
| Tax | $12.00M | -$8.00M | $21.00M | $241.00M | $24.00M |
| Net Profit | $342.00M | $303.00M | $53.00M | $963.00M | $31.00M |
| Profit from Continuing Operations | $342.00M | $303.00M | $53.00M | $963.00M | $31.00M |
| Net Income to Parent Company | $342.00M | $303.00M | $53.00M | $963.00M | $31.00M |
| Net Income to Common Stockholders | $342.00M | $303.00M | $53.00M | $963.00M | $31.00M |
| Basic EPS | $0.56 | $0.49 | $0.08 | $1.55 | $0.06 |
| Diluted EPS | $0.55 | $0.49 | $0.08 | $1.54 | $0.05 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $12.94B | $12.52B | $12.38B | $12.87B | $12.87B |
| Total Current Assets | $3.19B | $2.80B | $2.57B | $2.89B | $2.89B |
| Cash and Cash Equivalents & Short-Term Investments | $1.86B | $1.50B | $1.52B | $1.72B | $1.72B |
| -Cash and Cash Equivalents | $1.86B | $1.50B | $1.52B | $1.72B | $1.72B |
| Receivables | $1.30B | $1.28B | $1.03B | $1.15B | $1.15B |
| -Accounts Receivable | $1.24B | $1.21B | $968.00M | $1.11B | $1.11B |
| -Taxes Receivable | $57.00M | $68.00M | $63.00M | $40.00M | $40.00M |
| Inventory | $30.00M | $18.00M | $21.00M | $18.00M | $18.00M |
| Total Non-Current Assets | $9.75B | $9.71B | $9.80B | $9.99B | $9.99B |
| Net PPE | $314.00M | $254.00M | $265.00M | $280.00M | $280.00M |
| -Gross PPE | $314.00M | $254.00M | $265.00M | $437.00M | $437.00M |
| Investments and Advances | $39.00M | $36.00M | $40.00M | $37.00M | $37.00M |
| Goodwill and Other Intangible Assets | $9.20B | $9.23B | $9.30B | $9.48B | $9.48B |
| -Goodwill | $355.00M | $355.00M | $355.00M | $355.00M | $355.00M |
| -Other Intangible Assets | $8.84B | $8.87B | $8.95B | $9.12B | $9.12B |
| Non-Current Deferred Assets | $173.00M | $173.00M | $173.00M | $171.00M | $171.00M |
| Other Non-Current Assets | $25.00M | – | $22.00M | – | – |
| Total Liabilities | $6.60B | $6.56B | $6.69B | $7.03B | $7.03B |
| Total Current Liabilities | $1.30B | $1.14B | $1.18B | $1.43B | $1.43B |
| Payables | $932.00M | $807.00M | $861.00M | $1.11B | $1.11B |
| -Total Tax Payable | $0.00 | $0.00 | $0.00 | $43.00M | $43.00M |
| -Other Payable | $932.00M | $807.00M | $861.00M | $1.07B | $1.07B |
| Short-Term Debt and Capital Lease Obligation | $348.00M | $312.00M | $293.00M | $291.00M | $291.00M |
| -Current Debt | $318.00M | $294.00M | $275.00M | $273.00M | $273.00M |
| -Current Capital Lease Obligation | $30.00M | $18.00M | $18.00M | $18.00M | $18.00M |
| Current Deferred Liabilities | $19.00M | $21.00M | $24.00M | $24.00M | $24.00M |
| Total Non-Current Liabilities | $5.30B | $5.42B | $5.52B | $5.60B | $5.60B |
| Long Term Accounts Payable and Other Payables | $7.00M | $5.00M | $5.00M | $5.00M | $5.00M |
| Long Term Debt and Capital Lease Obligation | $4.85B | $4.96B | $5.06B | $5.14B | $5.14B |
| -Long Term Debt | $4.67B | $4.84B | $4.93B | $5.00B | $5.00B |
| -Long Term Capital Lease Obligation | $176.00M | $120.00M | $125.00M | $134.00M | $134.00M |
| Non-Current Deferred Liabilities | $447.00M | $452.00M | $453.00M | $459.00M | $459.00M |
| Total Equity | $6.33B | $5.96B | $5.68B | $5.85B | $5.85B |
| Stockholders' Equity | $6.33B | $5.96B | $5.68B | $5.85B | $5.85B |
| Capital Stock | $10.00M | $10.00M | $10.00M | $10.00M | $10.00M |
| -Common Stock | $10.00M | $10.00M | $10.00M | $10.00M | $10.00M |
| Additional Paid-In Capital | $1.94B | $1.92B | $1.92B | $1.92B | $1.92B |
| Retained Earnings | $4.80B | $4.42B | $4.09B | $4.10B | $4.10B |
| Gains/Losses Not Affecting Retained Earnings | -$414.00M | -$397.00M | -$340.00M | -$181.00M | -$181.00M |
| Non Current Accounts Receivables | – | $24.00M | – | $22.00M | $22.00M |
| -Short Term Investments | – | – | – | $0.00 | $0.00 |
| -Accumulated Depreciation | – | – | – | -$157.00M | -$157.00M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $520.00M | $51.00M | $3.00M | $1.19B | $301.00M |
| Net cash flow from continuing operations | $520.00M | $51.00M | $3.00M | $1.19B | $301.00M |
| Net Income from Continuing Operations | $354.00M | $295.00M | $74.00M | $1.20B | $55.00M |
| Gain/Loss from Continuing Operations | -$9.00M | $6.00M | $8.00M | -$62.00M | $7.00M |
| Depreciation & Depletion & Amortization | $27.00M | $26.00M | $29.00M | $71.00M | $21.00M |
| Other Non-Cash Items | $86.00M | $74.00M | $98.00M | -$77.00M | -$4.00M |
| Change in Working Capital | $26.00M | -$267.00M | -$113.00M | $225.00M | $253.00M |
| -Change in Receivables | -$12.00M | -$259.00M | $158.00M | -$166.00M | -$42.00M |
| -Change in Inventory | -$38.00M | $3.00M | -$3.00M | -$9.00M | -$4.00M |
| -Change in Payables and Accrued Expense | $84.00M | -$8.00M | -$261.00M | $400.00M | $299.00M |
| -Change In Other Working Capital | -$8.00M | -$3.00M | -$7.00M | – | – |
| Net cash flow from investing | -$9.00M | $2.00M | -$9.00M | -$5.64B | -$5.57B |
| Net Cash Flow from Continuing Investing Activities | -$9.00M | $2.00M | -$9.00M | -$5.64B | -$5.57B |
| Net PPE Purchase and Sale | -$4.00M | -$2.00M | -$5.00M | -$37.00M | -$13.00M |
| Net Intangibles Purchase and Sale | -$7.00M | -$1.00M | $0.00 | -$18.00M | $0.00 |
| Net Investment Purchase and Sale | $7.00M | $0.00 | -$4.00M | $1.63B | $1.66B |
| Financing Cash Flow | -$151.00M | -$75.00M | -$177.00M | $4.79B | $5.23B |
| Net Cash Flow from Continuing Financing Activities | -$151.00M | -$75.00M | -$177.00M | $4.79B | $5.23B |
| Net Issuance Payments Of Debt | -$164.00M | -$65.00M | -$69.00M | -$13.00M | -$2.00M |
| Net Common Stock Issuance | $0.00 | $0.00 | -$96.00M | $5.07B | $5.50B |
| Proceeds from Stock Option Exercised | $13.00M | $1.00M | $2.00M | $23.00M | $7.00M |
| Net Other Financing Charges | $0.00 | -$11.00M | -$14.00M | -$291.00M | -$276.00M |
| Ending Cash Balance | $1.86B | $1.50B | $1.52B | $1.72B | $1.72B |
| Net Change in Cash | $360.00M | -$22.00M | -$183.00M | $332.00M | -$42.00M |
| Beginning Cash Balance | $1.50B | $1.52B | $1.72B | $1.38B | $1.76B |
| Effect of Exchange Rate Changes | -$3.00M | $4.00M | -$11.00M | $3.00M | -$4.00M |
| Free Cash Flow | $509.00M | $48.00M | -$2.00M | $1.13B | $288.00M |
| Net Business Purchase and Sale | – | – | – | $0.00 | $0.00 |
| Net Other Investing Changes | – | – | – | -$7.22B | – |
No comments yet — be the first to weigh in on GMAB.
Sign in to join the discussion.